Related Experiment Video
Updated: May 31, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Almotriptan for menstrually related migraine
Gennaro Bussone1, Gianni Allais, Ilaria Castagnoli Gabellari
1Besta Neurological Institute, Via Celoria 11, Milan, Italy.
Almotriptan effectively treats menstrually related migraine (MRM), offering significant relief for women experiencing this severe headache type. It demonstrates excellent tolerability and symptom control, making it a preferred treatment option.
Area of Science:
- Neurology
- Pharmacology
Background:
- Menstrually related migraine (MRM) affects approximately 50% of women with migraines, often presenting as longer, more severe, and less responsive attacks.
- Effective treatment options for MRM are crucial due to its disabling nature.
Purpose of the Study:
- To provide an overview of MRM clinical features.
- To evaluate the efficacy and tolerability of almotriptan in treating MRM.
Main Methods:
- Review of four studies on almotriptan for MRM treatment.
- Inclusion of post hoc analyses, a dedicated MRM study, and a symptomatology subanalysis.
Main Results:
- Almotriptan demonstrates high efficacy in treating MRM.
- The drug exhibits an excellent tolerability profile compared to other triptans.
- Almotriptan effectively controls migraine-associated symptoms.
Conclusions:
- Almotriptan is a highly effective treatment for MRM.
- Its favorable tolerability and symptom control capabilities position it as a treatment of choice for MRM.
More Related Videos
05:36Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...